Mersana Therapeutics Inc

NASDAQ:MRSN   3:59:59 PM EDT
24.83
-0.68 (-2.67%)
Other Pre-Announcement

Mersana Therapeutics Announces Third Quarter 2020 Financial Results And Provides Business Update

Published: 11/09/2020 11:56 GMT
Mersana Therapeutics Inc (MRSN) - Mersana Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business Update.
Q3 Loss per Share $0.33.
Q3 Earnings per Share Estimate $-0.31 -- Refinitiv Ibes Data (analyst estimates).
Ended Q3 2020 With $271 Million in Cash.
Mersana Therapeutics - Sees Its Cash and Cash Equivalents Will Enable It to Fund Its Current Operating Plan Commitments for More Than Two Years.